chartexchange

POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN

GlobeNewswire Inc. | Nov 9, 2026 4:01 PM EST

TEL AVIV, Israel, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that its Board of Directors (the “Board”) has unanimously adopted a limited duration shareholder rights plan (the "Rights Plan"), effective immediately.

Read original article